IEFA Is a Great Choice for Most, but I Like VEA ETF Better

Key Points

• IEFA is an exchange-traded fund that follows large-, mid- and small-cap stocks from developed markets outside the U.S. and Canada.

• VEA does much of the same work, but includes stocks from Canada and South Korea.

• If you're looking for international exposure to stocks from developed companies, VEA is a slightly better pick.

• 10 stocks we like better than Vanguard Tax-Managed Funds - Vanguard Ftse Developed Markets ETF ›

Invest in Gold

American Hartford Gold: #1 Precious Metals Dealer in the Nation

Priority Gold: Up to $15k in Free Silver + Zero Account Fees on Qualifying Purchase

Thor Metals Group: Best Overall Gold IRA

For investors in the United States, it's pretty easy to get overexposed to domestic stocks. These are the brands that you're most used to and the companies that you see every day. It's easy to load up on what you know. Heck, even Warren Buffett makes that a central theme of his investing.

But you shouldn't forget about international exposure, and exchange-traded funds (ETFs) are some of the best ways to get there. ETFs give you exposure to hundreds or thousands of stocks with the click of a button. And that's why funds like the iShares Core MSCI EAFE ETF (NYSEMKT: IEFA) are so popular.

I actually think IEFA is a perfectly fine fund. But it's not my favorite for international exposure. There's a better option out there in the Vanguard FTSE Developed Markets ETF (NYSEMKT: VEA)

Let's take a look at these two funds.

IEFA provides a strong starting point

IEFA tracks the MSCI EAFE Investable Market Index, which is a market-cap weighted index that includes large-, mid-, and small-cap stocks from developed markets outside the U.S. and Canada. (EAFE stands for Europe, Australia and Asia, and the Far East.) Because it also excludes emerging markets, you won't find any stocks from nations like China, Brazil, or India.

In total, IEFA includes 2,605 companies, with the top holdings including ASML, Nestle, Novo Nordisk, and AstraZeneca. The heaviest weighting in the fund is 1.4%, so you know you're getting some serious diversification.

So far this year, IEFA is up 15.2%, which is better than the S&P 500's performance of 3.1%. Its five-year performance is nearly 39%.

With an expense ratio of 0.07%, investors can expect to pay just $7 annually for each $10,000 they invest. Clearly, IFEA is an excellent fund, and it's widely held for good reason.

Why VEA is the better choice

I'm not sure you could call IEFA vs. VEA an apples-to-oranges comparison. It's more like comparing a good apple to one that's a little shinier.

VEA tracks the FTSE Developed All Cap ex US Index. So it gives you access to small-, mid-, and large-cap stocks, in developed companies outside the U.S. But unlike IEFA, it also includes Canada and South Korea. That's why it tracks a whopping 3,839 companies, giving you even more diversification than IEFA.

Top holdings also include ASML, Nestle, Novo Nordisk, and AstraZeneca. But you also find Toyota Motor in the top 10 of the VEA. No stock has a weighting of more than 1.3%.

VEA also gives you slightly better returns. It's up nearly 16% so far this year and 40% in the last five years. And you get an even lower expense ratio of 0.03%, which means you're only paying $3 annually for each $10,000 you're investing.

Data source: Morningstar, author research.

The bottom line

There may be times when you want to invest in IEFA rather than VEA. For example, VEA might not be suitable if your portfolio already includes significant Canadian holdings, or is overweight in energy and natural resources, a sector where Canadian companies are prominent.

But in general, if you're looking for the efficient, affordable way to get international exposure from developed countries, VEA is the better choice. It's slightly cheaper, it offers more diversification, and it outperforms the IEFA. If you're building a set-it-and-forget-it portfolio, those little differences can add up in the long run.

Should you invest $1,000 in Vanguard Tax-Managed Funds - Vanguard Ftse Developed Markets ETF right now?

Before you buy stock in Vanguard Tax-Managed Funds - Vanguard Ftse Developed Markets ETF, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vanguard Tax-Managed Funds - Vanguard Ftse Developed Markets ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $966,931!*

Now, it’s worth noting Stock Advisor’s total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of June 23, 2025

Patrick Sanders has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML and Vanguard Tax-Managed Funds - Vanguard Ftse Developed Markets ETF. The Motley Fool recommends AstraZeneca Plc, Nestlé, and Novo Nordisk. The Motley Fool has a disclosure policy.

IEFA Is a Great Choice for Most, but I Like VEA ETF Better was originally published by The Motley Fool